We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+5.8%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$18.3B
AUM Growth
+$788M
(+4.5%)
Cap. Flow
-$100M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
46.77%
Holding
1,587
New
98
Increased
280
Reduced
424
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$59M |
| 2 |
Mondelez International
MDLZ
|
+$58.6M |
| 3 |
Mettler-Toledo International
MTD
|
+$55.5M |
| 4 |
Oracle
ORCL
|
+$45.4M |
| 5 |
Criteo
CRTO
|
+$34.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coty
COTY
|
+$87.8M |
| 2 |
CVS Health
CVS
|
+$47.4M |
| 3 |
Liberty Global Class C
LBTYK
|
+$46.4M |
| 4 |
GE Aerospace
GE
|
+$36M |
| 5 |
Kraft Heinz
KHC
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.19% |
| 2 | Healthcare | 10.79% |
| 3 | Industrials | 9.44% |
| 4 | Technology | 9.39% |
| 5 | Communication Services | 5.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNCE
551
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $463K | ﹤0.01% |
17,900
-51,000
| -74% | -$1.03M |
|
552
Vanguard Large-Cap ETF
VV
$51.9B
| $459K | ﹤0.01% |
3,745
+3,045
| +435% | +$364K |
|
553
Opko Health
OPK
$921M
| $453K | ﹤0.01% |
92,550
-6,000
| -6% | -$34.8K |
|
554
Cadiz
CDZI
$266M
| $448K | ﹤0.01% |
31,500
| – | – |
|
|
MAG
555
DELISTED
MAG Silver
MAG
| $444K | ﹤0.01% |
36,000
| – | – |
|
556
Hilltop Holdings
HTH
$2.29B
| $443K | ﹤0.01% |
17,500
| – | – |
|
557
VF Corp
VFC
$6.68B
| $440K | ﹤0.01% |
6,317
| – | – |
|
558
First Bank
FRBA
$451M
| $439K | ﹤0.01% |
+31,703
| New | +$423K |
|
|
WR
559
DELISTED
Westar Energy Inc
WR
| $438K | ﹤0.01% |
8,310
-125
| -1% | -$6.74K |
|
560
APA Corp
APA
$12.8B
| $435K | ﹤0.01% |
10,309
-846
| -8% | -$35.6K |
|
561
Mattel
MAT
$4.17B
| $433K | ﹤0.01% |
28,155
-33,585
| -54% | -$532K |
|
562
Harvard Bioscience
HBIO
$27.1M
| $432K | ﹤0.01% |
13,100
| – | – |
|
563
Roper Technologies
ROP
$36.3B
| $431K | ﹤0.01% |
+1,667
| New | +$428K |
|
564
SBA Communications
SBAC
$18.4B
| $429K | ﹤0.01% |
2,630
+2,578
| +4,958% | +$410K |
|
565
Coca-Cola Europacific Partners
CCEP
$46.5B
| $427K | ﹤0.01% |
10,735
| – | – |
|
566
Invesco QQQ Trust
QQQ
$455B
| $422K | ﹤0.01% |
2,712
+726
| +37% | +$111K |
|
567
Thomson Reuters
TRI
$39.4B
| $418K | ﹤0.01% |
8,272
-2,909
| -26% | -$152K |
|
568
Fidelity National Information Services
FIS
$21.5B
| $412K | ﹤0.01% |
4,381
+61
| +1% | +$5.73K |
|
569
Public Service Enterprise Group
PEG
$39.8B
| $412K | ﹤0.01% |
8,007
-399
| -5% | -$20.1K |
|
570
Illumina
ILMN
$29.4B
| $409K | ﹤0.01% |
1,924
| – | – |
|
571
Landmark Bancorp
LARK
$192M
| $409K | ﹤0.01% |
20,869
-1
| -0% | -$19 |
|
572
Dominion Energy
D
$62.5B
| $402K | ﹤0.01% |
4,960
+560
| +13% | +$45.4K |
|
|
IFN
573
Aberdeen India Fund
IFN
$488M
| $399K | ﹤0.01% |
15,297
| – | – |
|
|
IDTI
574
DELISTED
Integrated Device Technology I
IDTI
| $392K | ﹤0.01% |
13,200
| – | – |
|
575
Cinemark Holdings
CNK
$3.82B
| $391K | ﹤0.01% |
11,250
| – | – |
|
Similar funds
SAM
First Manhattan's Q4 2017 Portfolio in Review
As of Q4 2017, First Manhattan held 1,587 positions worth $18.3B, up 4.5% from $17.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
First Manhattan's Q4 2017 filing shows 98 new, 280 increased, 424 reduced and 89 closed positions. Its largest new stake was Ulta Beauty: 278,688 shares worth $62.3M. The largest sale was Coty, an estimated $87.8M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q4 2017 buy was Ulta Beauty: 278,688 shares worth $62.3M.
- First Manhattan added most to Mondelez International in Q4 2017, an estimated $58.6M increase.
- First Manhattan's biggest Q4 2017 reduction was Coty, cutting an estimated $87.8M.
- First Manhattan fully exited Clovis Oncology, Inc. in Q4 2017, selling an estimated $8.33M.
- First Manhattan's ten largest holdings make up 47% of its $18.3B portfolio in Q4 2017.
- First Manhattan opened 98 new positions and closed 89 in Q4 2017.
- First Manhattan's portfolio value rose 4.5% quarter-over-quarter to $18.3B.
Based on First Manhattan's 13F filing for Q4 2017, filed 22 Jan 2018.